USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
13 Jun 2023 | 02:45 PM GMT

Existing and New Distribution Channels for DTx

Anchored by:

Ed Melendez
Advisor
PEER COLLECTIVE

Participants:

Ed Melendez AdvisorPeer Collective
Ed Melendez
AdvisorPeer Collective
Myles Furnace Chief Commercial OfficerEolas Medical
Myles Furnace
Chief Commercial OfficerEolas Medical
Anne Muth Market Intelligence ManagerSidekickHealth
Anne Muth
Market Intelligence ManagerSidekickHealth
Matt Norton VP of Marketing & Commercial DevelopmentS3 Connected Health
Matt Norton
VP of Marketing & Commercial DevelopmentS3 Connected Health
Pete Brockmeier Assoc. Director - Digital Health PartnershipsNovo Nordisk
Pete Brockmeier
Assoc. Director - Digital Health PartnershipsNovo Nordisk
Renae Beaumont Associate Professor of PsychologyWeill Cornell Medicine
Renae Beaumont
Associate Professor of PsychologyWeill Cornell Medicine

About this Meeting

Small, intimate and participant-led discussions tackling digital health challenges. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

Digital therapeutics (DTx) are yet to show success at scale with traditional salesforce distribution channels. The traditional salesforce model is built around selling drugs to physicians and other healthcare providers (HCPs) through personal interactions. However, as DTx do not necessitate HCPs for adoption, and can go through other market strategies (e.g. B2B, B2C), it is not surprising that the same models that work for drugs, are not as effective for DTx. Therefore, new models need to be explored and experimented with when commercialising and distributing DTx to promote widespread adoption. If you are looking for new distribution channels and options for commercialising your DTx solution, don’t miss out on this meeting! During this meeting, we will discuss the future of DTx distribution and the opportunities available for companies seeking to promote and distribute their DTx solutions. Specifically, the meeting will cover:
  • Challenges with traditional salesforce team distribution models for DTx.
  • Existing distribution channels (e.g. pharmacies, telehealth platforms, etc.) that DTx could consider as alternative distribution channels.
  • New distribution channels that can be tapped into. Are there other distribution channels for DTx that may show viability? For example, could a subscription-based model similar to that which Amazon recently launched work for DTx?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.